Gene · 9219
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses. | Virology | 2023 | 37084644 | PubTator, text mining | PubMed |
| OsbHLH067, OsbHLH068, and OsbHLH069 redundantly regulate inflorescence axillary meristem formation in rice. | PLoS Genet | 2023 | 37053298 | PubTator, text mining | PubMed |
| Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37041757 | PubTator, text mining | PubMed |
| Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment. | Front Immunol | 2023 | 37033948 | PubTator, text mining | PubMed |
| Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms. | Sci Rep | 2023 | 37031292 | PubTator, text mining | PubMed |
| Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution. | Cell Rep Med | 2023 | 37023747 | PubTator, text mining | PubMed |
| The stem cell-supporting small molecule UM171 triggers Cul3-KBTBD4-mediated degradation of ELM2 domain-harboring proteins. | J Biol Chem | 2023 | 36997086 | PubTator, text mining | PubMed |
| MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2. | Cancers (Basel) | 2023 | 36980601 | PubTator, text mining | PubMed |
| Effects of the Acetyltransferase p300 on Tumour Regulation from the Novel Perspective of Posttranslational Protein Modification. | Biomolecules | 2023 | 36979352 | PubTator, text mining | PubMed |
| Linguistic profile automated characterisation in pluripotential clinical high-risk mental state (CHARMS) conditions: methodology of a multicentre observational study. | BMJ Open | 2023 | 36948562 | PubTator, text mining | PubMed |
| Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer. | Front Genet | 2023 | 36936412 | PubTator, text mining | PubMed |
| The novel GATA1-interacting protein HES6 is an essential transcriptional cofactor for human erythropoiesis. | Nucleic Acids Res | 2023 | 36929421 | PubTator, text mining | PubMed |
| Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients. | Genet Res (Camb) | 2023 | 36923953 | PubTator, text mining | PubMed |
| Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss. | Oncotarget | 2023 | 36913304 | PubTator, text mining | PubMed |
| USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis. | Blood Adv | 2023 | 36912760 | PubTator, text mining | PubMed |
| Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors. | Front Oncol | 2023 | 36910646 | PubTator, text mining | PubMed |
| Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis. | Mol Cell Biochem | 2023 | 36905477 | PubTator, text mining | PubMed |
| Elevated Levels of Lamin A Promote HR and NHEJ-Mediated Repair Mechanisms in High-Grade Ovarian Serous Carcinoma Cell Line. | Cells | 2023 | 36899893 | PubTator, text mining | PubMed |
| Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors. | J Immunother Cancer | 2023 | 36898736 | PubTator, text mining | PubMed |
| hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex. | J Mol Cell Biol | 2023 | 36881716 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9219/papers?page=9